Molecular studies on tumor tissues showed an increase in the local expression of IL-7 and the number of CD8+ T cells in the CTSS-knockdown group, which was counteracted by αIL-7 (Fig. 2C and S2). This evidence concerns the gene CD8A and neoplasm.